Houston drives to top of list of Texas cities for worst traffic congestion

slow moving

According to a report, Houston traffic is actually the worst. Local.AllState.com

Honk if you hate Houston traffic. According to a new study, you’re more than justified in laying on the horn to express frustration over Houston’s clogged roads.

The study, released by geolocation technology company TomTom, shows the typical Houston driver wasted 46 hours last year due to traffic congestion. Houston’s traffic congestion rate was 20 percent. This means average travel times in jammed-up traffic were 20 percent longer than they were in uncongested traffic.

While those figures alone highlight the drive-me-up-a-wall status of Houston commutes, what’s worse is that the city ranks first in Texas, No. 16 in the U.S., and No. 214 in the world for snarled traffic in 2021. The study says Houston’s traffic congestion went up 4 percent compared with 2020 but went down 4 percent compared with pre-pandemic 2019.

Where’s the worst of the worst traffic in Houston? According to Texas A&M Transportation Institute data published in December, the 610 West Loop was the state’s most congested stretch of roadway in 2020, trading places with I-35 in Austin, which held the top spot in 2019.

On top of that, Houston is home to 10 of the 14 worst trucking bottlenecks in Texas, according to an American Transportation Research Institute ranking released earlier this month. The absolute worst: I-45 at I-69 and U.S. Highway 59. The institute deemed that intersection the third worst trucking bottleneck in the country for 2021.

“Bottlenecks around the state continue to waste time and money, further damaging the already fragile supply chain,” John Esparza, president and CEO of the Texas Trucking Association, says in a news release. “With the newly available federal resources for infrastructure projects, there’s no excuse — these bottlenecks must be addressed. A reliable and stable transportation network is essential to our economy — just like the trucking industry.”

Here’s how other major Texas cities fared in the TomTom study:

  • McAllen ranked second in Texas, 18th in the U.S., and 218th in the world for traffic congestion. Time wasted in traffic last year for a typical driver: 46 hours. Congestion rate: 20 percent. Congestion up 4 percent from 2020 and up 1 percent from 2019.
  • Austin ranked third in Texas, 21st in the U.S., and 221st in the world for traffic congestion. Time wasted in traffic last year for a typical driver: 46 hours. Congestion rate: 20 percent. Congestion up 2 percent from 2020 and down 7 percent from 2019.
  • Dallas-Fort Worth ranked fourth in Texas, 37th in the U.S., and 305th in the world for traffic congestion. Time wasted in traffic last year for a typical driver: 39 hours. Congestion rate: 17 percent. Congestion up 4 percent from 2020 but down 2 percent from 2019.=
  • San Antonio ranked fifth in Texas, 41st in the U.S., and 318th in the world for traffic congestion. Time wasted in traffic last year for a typical driver: 36 hours. Congestion rate: 16 percent. Congestion up 3 percent from 2020 and down 3 percent from 2019.
  • El Paso ranked sixth in Texas, 44th in the U.S., and 324th in the world for traffic congestion. Time wasted in traffic last year for a typical driver: 36 hours. Congestion rate: 16 percent. Congestion up 4 percent from 2020 and the same as 2019.

Not surprisingly, the TomTom study awards New York City the title of the worst-congested place in the country. In 2021, the typical New York driver wasted 80 hours in traffic, with a 35 percent congestion rate.

Racking up a congestion rate of 62 percent last year, Istanbul, Turkey, claimed the title of the world’s worst city for traffic. There, motorists wasted 142 hours in traffic in 2021.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston's Ion District to expand with new research and tech space, The Arc

coming soon

Houston's Ion District is set to expand with the addition of a nearly 200,000-square-foot research and technology facility, The Arc at the Ion District.

Rice Real Estate Company and Lincoln Property Company are expected to break ground on the state-of-the-art facility in Q2 2026 with a completion target set for Q1 2028, according to a news release.

Rice University, the new facility's lead tenant, will occupy almost 30,000 square feet of office and lab space in The Arc, which will share a plaza with the Ion and is intended to "extend the district’s success as a hub for innovative ideas and collaboration." Rice research at The Arc will focus on energy, artificial intelligence, data science, robotics and computational engineering, according to the release.

“The Arc will offer Rice the opportunity to deepen its commitment to fostering world-changing innovation by bringing our leading minds and breakthrough discoveries into direct engagement with Houston’s thriving entrepreneurial ecosystem,” Rice President Reginald DesRoches said in the release. “Working side by side with industry experts and actual end users at the Ion District uniquely positions our faculty and students to form partnerships and collaborations that might not be possible elsewhere.”

Developers of the project are targeting LEED Gold certification by incorporating smart building automation and energy-saving features into The Arc's design. Tenants will have the opportunity to lease flexible floor plans ranging from 28,000 to 31,000 square feet with 15-foot-high ceilings. The property will also feature a gym, an amenity lounge, conference and meeting spaces, outdoor plazas, underground parking and on-site retail and dining.

Preleasing has begun for organizations interested in joining Rice in the building.

“The Arc at the Ion District will be more than a building—it will be a catalyst for the partnerships, innovations and discoveries that will define Houston’s future in science and technology,” Ken Jett, president of Rice Real Estate Company, added in the release. “By expanding our urban innovation ecosystem, The Arc will attract leading organizations and talent to Houston, further strengthening our city’s position as a hub for scientific and entrepreneurial progress.”

Intel Corp. and Rice University sign research access agreement

innovation access

Rice University’s Office of Technology Transfer has signed a subscription agreement with California-based Intel Corp., giving the global company access to Rice’s research portfolio and the opportunity to license select patented innovations.

“By partnering with Intel, we are creating opportunities for our research to make a tangible impact in the technology sector,” Patricia Stepp, assistant vice president for technology transfer, said in a news release.

Intel will pay Rice an annual subscription fee to secure the option to evaluate specified Rice-patented technologies, according to the agreement. If Intel chooses to exercise its option rights, it can obtain a license for each selected technology at a fee.

Rice has been a hub for innovation and technology with initiatives like the Rice Biotech Launch Pad, an accelerator focused on expediting the translation of the university’s health and medical technology; RBL LLC, a biotech venture studio in the Texas Medical Center’s Helix Park dedicated to commercializing lifesaving medical technologies from the Launch Pad; and Rice Nexus, an AI-focused "innovation factory" at the Ion.

The university has also inked partnerships with other tech giants in recent months. Rice's OpenStax, a provider of affordable instructional technologies and one of the world’s largest publishers of open educational resources, partnered with Microsoft this summer. Google Public Sector has also teamed up with Rice to launch the Rice AI Venture Accelerator, or RAVA.

“This agreement exemplifies Rice University’s dedication to fostering innovation and accelerating the commercialization of groundbreaking research,” Stepp added in the news release.

Houston team develops low-cost device to treat infants with life-threatening birth defect

infant innovation

A team of engineers and pediatric surgeons led by Rice University’s Rice360 Institute for Global Health Technologies has developed a cost-effective treatment for infants born with gastroschisis, a congenital condition in which intestines and other organs are developed outside of the body.

The condition can be life-threatening in economically disadvantaged regions without access to equipment.

The Rice-developed device, known as SimpleSilo, is “simple, low-cost and locally manufacturable,” according to the university. It consists of a saline bag, oxygen tubing and a commercially available heat sealer, while mimicking the function of commercial silo bags, which are used in high-income countries to protect exposed organs and gently return them into the abdominal cavity gradually.

Generally, a single-use bag can cost between $200 and $300. The alternatives that exist lack structure and require surgical sewing. This is where the SimpleSilo comes in.

“We focused on keeping the design as simple and functional as possible, while still being affordable,” Vanshika Jhonsa said in a news release. “Our hope is that health care providers around the world can adapt the SimpleSilo to their local supplies and specific needs.”

The study was published in the Journal of Pediatric Surgery, and Jhonsa, its first author, also won the 2023 American Pediatric Surgical Association Innovation Award for the project. She is a recent Rice alumna and is currently a medical student at UTHealth Houston.

Bindi Naik-Mathuria, a pediatric surgeon at UTMB Health, served as the corresponding author of the study. Rice undergraduates Shreya Jindal and Shriya Shah, along with Mary Seifu Tirfie, a current Rice360 Global Health Fellow, also worked on the project.

In laboratory tests, the device demonstrated a fluid leakage rate of just 0.02 milliliters per hour, which is comparable to commercial silo bags, and it withstood repeated disinfection while maintaining its structure. In a simulated in vitro test using cow intestines and a mock abdominal wall, SimpleSilo achieved a 50 percent reduction of the intestines into the simulated cavity over three days, also matching the performance of commercial silo bags. The team plans to conduct a formal clinical trial in East Africa.

“Gastroschisis has one of the biggest survival gaps from high-resource settings to low-resource settings, but it doesn’t have to be this way,” Meaghan Bond, lecturer and senior design engineer at Rice360, added in the news release. “We believe the SimpleSilo can help close the survival gap by making treatment accessible and affordable, even in resource-limited settings.”
View All Listings